NRXP sets 2026 Annual Meeting date
- Meeting on Dec 17, 2026
- Record date Oct 28, 2026
- Virtual-only format
NRXP
NRX Pharmaceuticals, Inc. SEC filings
Every EDGAR filing for NRX Pharmaceuticals, Inc. (NRXP), newest first, with AI summaries and stories.
- Ticker
- NRXP
- CIK
- 1719406
- Sector
- Biotech and pharma
- Latest filing
- 2d
Next: earnings expected ~Nov 16 ยท 10-Q expected ~Nov 16 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE NRX Pharmaceuticals wins $11.2M DARPA contract
- Contract value: $11.2M
- DARPA awarded the contract
- SPARC-TMS trial to treat depression
ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE NOTABLE10-QNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE424B5NRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE424B5NRX Pharmaceuticals, Inc.NRXPWLIVE NOTABLE25-NSENRX Pharmaceuticals, Inc.NRXPWLIVE Nasdaq Stock Market LLC, filed by
NOTABLE10-QNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINESCHEDULE 13G/ANRX Pharmaceuticals, Inc.NRXPWLIVE Ownership stake disclosure by Anson Funds Management LP (amended)
Anson Funds Management LP, filed by
ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE NOTABLE10-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINEDEFA14ANRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINEARSNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINEDEF 14ANRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE4NRX Pharmaceuticals, Inc.NRXPWLIVE 2 insider filings
Joseph Michael Casper, insider filing for NRXPW
Show all 2
- 4Insider filing for NRXPW
- 3New insider at NRXPW
Joseph Michael Casper, reporting
ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE424B5NRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINEPRE 14ANRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINEEFFECTNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE424B3NRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINES-3/ANRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-KNRX Pharmaceuticals, Inc.NRXPWLIVE ROUTINE8-K/ANRX Pharmaceuticals, Inc.NRXPWLIVE NRX Pharmaceuticals, Inc. filed 8-K/A
- Form Type: 8-K/A
- Filing Date: 2025-11-21
NOTABLE10-QNRX Pharmaceuticals, Inc.NRXPWLIVE